US HB3839 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on June 6 2023 - 25% progression
Action: 2023-06-09 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 6 2023 - 25% progression
Action: 2023-06-09 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Title
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Sponsors
| Rep. Neal Dunn [R-FL] | Rep. Ann Kuster [D-NH] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-06-09 | House | Referred to the Subcommittee on Health. |
| 2023-06-06 | House | Referred to the House Committee on Energy and Commerce. |
| 2023-06-06 | House | Introduced in House |
Same As/Similar To
HB3561 (Related) 2023-05-24 - Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
SB775 (Related) 2023-03-14 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB1114 (Related) 2023-06-22 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 108.
HB5378 (Related) 2023-12-11 - Motion to reconsider laid on the table Agreed to without objection.
SB775 (Related) 2023-03-14 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB1114 (Related) 2023-06-22 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 108.
HB5378 (Related) 2023-12-11 - Motion to reconsider laid on the table Agreed to without objection.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/3839/all-info |
| Text | https://www.congress.gov/118/bills/hr3839/BILLS-118hr3839ih.pdf |
